Why Medicine Shortages Happen So Often

Shortages of ordinary medicines have become common, and they rarely involve exotic drugs. The causes sit in how these products are manufactured and priced rather than in demand.

Production is concentrated in very few places

The active ingredient in a given medicine is often made at a small number of sites worldwide, sometimes only one or two.

Concentration exists because chemical manufacturing rewards scale heavily. A single large plant produces far more cheaply than several smaller ones.

The consequence is that a fire, a flood, a regulatory suspension or a quality failure at one site removes a large share of global supply at once.

Old medicines carry very thin margins

Once a medicine loses patent protection, competition drives its price down until margins are minimal, which is the intended outcome for affordability.

Thin margins leave no room to hold buffer stock, maintain spare capacity or invest in ageing production lines.

They also make exit rational. A manufacturer facing a costly plant upgrade on a low-margin product may simply stop making it, and the remaining producers cannot absorb the volume.

Quality regulation removes capacity quickly

Pharmaceutical plants are inspected against strict standards, and failure can halt production immediately.

This is a feature rather than a fault, since contaminated or sub-potent medicine is more dangerous than none. But the effect on supply is abrupt.

Restarting is slow. Batches must be validated, tested and released, which means a suspension of weeks can translate into a shortage lasting months.

The system has almost no slack

Supply chains have been optimised toward low inventory, so stock in transit and on shelves is deliberately kept small.

Efficient systems have little tolerance for shocks. A modest disruption propagates because nobody in the chain holds enough to cushion it.

Buying behaviour amplifies this. Once a shortage is reported, pharmacies and patients order ahead, and precautionary demand empties the remaining stock faster than the underlying problem would.

What happens at the counter

Pharmacies manage shortages by sourcing from alternative wholesalers, splitting supply across patients or asking the prescriber to authorise a different formulation.

Switching is not always simple. A different strength changes how many tablets are taken, and a different form may not be interchangeable for a particular patient.

Anyone affected by a shortage of a medicine they depend on should raise it with their prescriber or pharmacist early rather than waiting until the supply runs out.